ATR_HUMAN - dbPTM
ATR_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ATR_HUMAN
UniProt AC Q13535
Protein Name Serine/threonine-protein kinase ATR
Gene Name ATR
Organism Homo sapiens (Human).
Sequence Length 2644
Subcellular Localization Nucleus . Nucleus, PML body . Chromosome . Depending on the cell type, it can also be found in PML nuclear bodies. Recruited to chromatin during S-phase. Redistributes to discrete nuclear foci upon DNA damage, hypoxia or replication fork stalling.
Protein Description Serine/threonine protein kinase which activates checkpoint signaling upon genotoxic stresses such as ionizing radiation (IR), ultraviolet light (UV), or DNA replication stalling, thereby acting as a DNA damage sensor. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates BRCA1, CHEK1, MCM2, RAD17, RPA2, SMC1 and p53/TP53, which collectively inhibit DNA replication and mitosis and promote DNA repair, recombination and apoptosis. Phosphorylates 'Ser-139' of histone variant H2AX/H2AFX at sites of DNA damage, thereby regulating DNA damage response mechanism. Required for FANCD2 ubiquitination. Critical for maintenance of fragile site stability and efficient regulation of centrosome duplication..
Protein Sequence MGEHGLELASMIPALRELGSATPEEYNTVVQKPRQILCQFIDRILTDVNVVAVELVKKTDSQPTSVMLLDFIQHIMKSSPLMFVNVSGSHEAKGSCIEFSNWIITRLLRIAATPSCHLLHKKICEVICSLLFLFKSKSPAIFGVLTKELLQLFEDLVYLHRRNVMGHAVEWPVVMSRFLSQLDEHMGYLQSAPLQLMSMQNLEFIEVTLLMVLTRIIAIVFFRRQELLLWQIGCVLLEYGSPKIKSLAISFLTELFQLGGLPAQPASTFFSSFLELLKHLVEMDTDQLKLYEEPLSKLIKTLFPFEAEAYRNIEPVYLNMLLEKLCVMFEDGVLMRLKSDLLKAALCHLLQYFLKFVPAGYESALQVRKVYVRNICKALLDVLGIEVDAEYLLGPLYAALKMESMEIIEEIQCQTQQENLSSNSDGISPKRRRLSSSLNPSKRAPKQTEEIKHVDMNQKSILWSALKQKAESLQISLEYSGLKNPVIEMLEGIAVVLQLTALCTVHCSHQNMNCRTFKDCQHKSKKKPSVVITWMSLDFYTKVLKSCRSLLESVQKLDLEATIDKVVKIYDALIYMQVNSSFEDHILEDLCGMLSLPWIYSHSDDGCLKLTTFAANLLTLSCRISDSYSPQAQSRCVFLLTLFPRRIFLEWRTAVYNWALQSSHEVIRASCVSGFFILLQQQNSCNRVPKILIDKVKDDSDIVKKEFASILGQLVCTLHGMFYLTSSLTEPFSEHGHVDLFCRNLKATSQHECSSSQLKASVCKPFLFLLKKKIPSPVKLAFIDNLHHLCKHLDFREDETDVKAVLGTLLNLMEDPDKDVRVAFSGNIKHILESLDSEDGFIKELFVLRMKEAYTHAQISRNNELKDTLILTTGDIGRAAKGDLVPFALLHLLHCLLSKSASVSGAAYTEIRALVAAKSVKLQSFFSQYKKPICQFLVESLHSSQMTALPNTPCQNADVRKQDVAHQREMALNTLSEIANVFDFPDLNRFLTRTLQVLLPDLAAKASPAASALIRTLGKQLNVNRREILINNFKYIFSHLVCSCSKDELERALHYLKNETEIELGSLLRQDFQGLHNELLLRIGEHYQQVFNGLSILASFASSDDPYQGPRDIISPELMADYLQPKLLGILAFFNMQLLSSSVGIEDKKMALNSLMSLMKLMGPKHVSSVRVKMMTTLRTGLRFKDDFPELCCRAWDCFVRCLDHACLGSLLSHVIVALLPLIHIQPKETAAIFHYLIIENRDAVQDFLHEIYFLPDHPELKKIKAVLQEYRKETSESTDLQTTLQLSMKAIQHENVDVRIHALTSLKETLYKNQEKLIKYATDSETVEPIISQLVTVLLKGCQDANSQARLLCGECLGELGAIDPGRLDFSTTETQGKDFTFVTGVEDSSFAYGLLMELTRAYLAYADNSRAQDSAAYAIQELLSIYDCREMETNGPGHQLWRRFPEHVREILEPHLNTRYKSSQKSTDWSGVKKPIYLSKLGSNFAEWSASWAGYLITKVRHDLASKIFTCCSIMMKHDFKVTIYLLPHILVYVLLGCNQEDQQEVYAEIMAVLKHDDQHTINTQDIASDLCQLSTQTVFSMLDHLTQWARHKFQALKAEKCPHSKSNRNKVDSMVSTVDYEDYQSVTRFLDLIPQDTLAVASFRSKAYTRAVMHFESFITEKKQNIQEHLGFLQKLYAAMHEPDGVAGVSAIRKAEPSLKEQILEHESLGLLRDATACYDRAIQLEPDQIIHYHGVVKSMLGLGQLSTVITQVNGVHANRSEWTDELNTYRVEAAWKLSQWDLVENYLAADGKSTTWSVRLGQLLLSAKKRDITAFYDSLKLVRAEQIVPLSAASFERGSYQRGYEYIVRLHMLCELEHSIKPLFQHSPGDSSQEDSLNWVARLEMTQNSYRAKEPILALRRALLSLNKRPDYNEMVGECWLQSARVARKAGHHQTAYNALLNAGESRLAELYVERAKWLWSKGDVHQALIVLQKGVELCFPENETPPEGKNMLIHGRAMLLVGRFMEETANFESNAIMKKYKDVTACLPEWEDGHFYLAKYYDKLMPMVTDNKMEKQGDLIRYIVLHFGRSLQYGNQFIYQSMPRMLTLWLDYGTKAYEWEKAGRSDRVQMRNDLGKINKVITEHTNYLAPYQFLTAFSQLISRICHSHDEVFVVLMEIIAKVFLAYPQQAMWMMTAVSKSSYPMRVNRCKEILNKAIHMKKSLEKFVGDATRLTDKLLELCNKPVDGSSSTLSMSTHFKMLKKLVEEATFSEILIPLQSVMIPTLPSILGTHANHASHEPFPGHWAYIAGFDDMVEILASLQKPKKISLKGSDGKFYIMMCKPKDDLRKDCRLMEFNSLINKCLRKDAESRRRELHIRTYAVIPLNDECGIIEWVNNTAGLRPILTKLYKEKGVYMTGKELRQCMLPKSAALSEKLKVFREFLLPRHPPIFHEWFLRTFPDPTSWYSSRSAYCRSTAVMSMVGYILGLGDRHGENILFDSLTGECVHVDFNCLFNKGETFEVPEIVPFRLTHNMVNGMGPMGTEGLFRRACEVTMRLMRDQREPLMSVLKTFLHDPLVEWSKPVKGHSKAPLNETGEVVNEKAKTHVLDIEQRLQGVIKTRNRVTGLPLSIEGHVHYLIQEATDENLLCQMYLGWTPYM
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
20PhosphorylationPALRELGSATPEEYN
HHHHHHCCCCHHHHH
41.4129954749
26PhosphorylationGSATPEEYNTVVQKP
CCCCHHHHHHHCCCH
17.9322817900
32UbiquitinationEYNTVVQKPRQILCQ
HHHHHCCCHHHHHHH
30.4721906983
32 (in isoform 1)Ubiquitination-30.4721890473
32 (in isoform 2)Ubiquitination-30.4721890473
32 (in isoform 3)Ubiquitination-30.4721906983
58UbiquitinationVAVELVKKTDSQPTS
EEEEEHHCCCCCCCH
50.51-
61PhosphorylationELVKKTDSQPTSVML
EEHHCCCCCCCHHHH
43.20-
177MethylationEWPVVMSRFLSQLDE
HHHHHHHHHHHHHHH
20.59-
291PhosphorylationDTDQLKLYEEPLSKL
CHHHHHHCHHHHHHH
19.3622817900
297UbiquitinationLYEEPLSKLIKTLFP
HCHHHHHHHHHHHCC
63.0129967540
300UbiquitinationEPLSKLIKTLFPFEA
HHHHHHHHHHCCCCH
50.00-
310PhosphorylationFPFEAEAYRNIEPVY
CCCCHHHHHCCCHHH
8.8322817900
317PhosphorylationYRNIEPVYLNMLLEK
HHCCCHHHHHHHHHH
11.7622817900
415PhosphorylationIEEIQCQTQQENLSS
HHHHHHHHHHHHHCC
39.5930108239
421PhosphorylationQTQQENLSSNSDGIS
HHHHHHHCCCCCCCC
38.7730108239
422PhosphorylationTQQENLSSNSDGISP
HHHHHHCCCCCCCCH
43.4430108239
424PhosphorylationQENLSSNSDGISPKR
HHHHCCCCCCCCHHH
38.8830108239
428PhosphorylationSSNSDGISPKRRRLS
CCCCCCCCHHHHHHH
29.8730278072
435PhosphorylationSPKRRRLSSSLNPSK
CHHHHHHHHCCCCCC
18.9722322096
435 (in isoform 2)Phosphorylation-18.9725849741
436PhosphorylationPKRRRLSSSLNPSKR
HHHHHHHHCCCCCCC
43.3630266825
436 (in isoform 2)Phosphorylation-43.3629116813
437PhosphorylationKRRRLSSSLNPSKRA
HHHHHHHCCCCCCCC
28.8830266825
437 (in isoform 2)Phosphorylation-28.8829116813
441PhosphorylationLSSSLNPSKRAPKQT
HHHCCCCCCCCCCCC
33.4323927012
442UbiquitinationSSSLNPSKRAPKQTE
HHCCCCCCCCCCCCH
54.5622817900
442 (in isoform 1)Ubiquitination-54.5621890473
442 (in isoform 2)Ubiquitination-54.5621890473
442 (in isoform 3)Ubiquitination-54.5621906983
446UbiquitinationNPSKRAPKQTEEIKH
CCCCCCCCCCHHCCC
69.7122817900
459UbiquitinationKHVDMNQKSILWSAL
CCCCCCHHHHHHHHH
34.1629967540
464PhosphorylationNQKSILWSALKQKAE
CHHHHHHHHHHHHHH
21.9327251275
480PhosphorylationLQISLEYSGLKNPVI
CCCHHHHCCCCCHHH
28.4211418864
533PhosphorylationKKPSVVITWMSLDFY
CCCCEEEEEEEHHHH
11.96-
549PhosphorylationKVLKSCRSLLESVQK
HHHHHHHHHHHHHHH
41.4511418864
625PhosphorylationLTLSCRISDSYSPQA
HHHHCCCCCCCCHHH
10.9328270605
627PhosphorylationLSCRISDSYSPQAQS
HHCCCCCCCCHHHHH
22.2528270605
628PhosphorylationSCRISDSYSPQAQSR
HCCCCCCCCHHHHHH
29.3928270605
629PhosphorylationCRISDSYSPQAQSRC
CCCCCCCCHHHHHHH
17.9428270605
634PhosphorylationSYSPQAQSRCVFLLT
CCCHHHHHHHEHHHH
30.5728270605
682UbiquitinationFFILLQQQNSCNRVP
HHHHHCCCCCCCCCC
30.7321963094
695UbiquitinationVPKILIDKVKDDSDI
CCEEHHHCCCCCCHH
44.1629967540
746MethylationDLFCRNLKATSQHEC
HHHCCCCCCCCCCCC
53.84-
746UbiquitinationDLFCRNLKATSQHEC
HHHCCCCCCCCCCCC
53.8421963094
759MethylationECSSSQLKASVCKPF
CCCHHHHHHHHHHHH
30.86-
764AcetylationQLKASVCKPFLFLLK
HHHHHHHHHHHHHHH
36.3326051181
764UbiquitinationQLKASVCKPFLFLLK
HHHHHHHHHHHHHHH
36.33-
771AcetylationKPFLFLLKKKIPSPV
HHHHHHHHCCCCCCC
54.9226051181
776PhosphorylationLLKKKIPSPVKLAFI
HHHCCCCCCCHHHHH
45.8824702127
791UbiquitinationDNLHHLCKHLDFRED
HCHHHHHHCCCCCCC
54.2729967540
802UbiquitinationFREDETDVKAVLGTL
CCCCHHHHHHHHHHH
5.8321963094
802 (in isoform 2)Ubiquitination-5.8321890473
818UbiquitinationNLMEDPDKDVRVAFS
HHHCCCCCCCEEEEC
64.6129967540
851UbiquitinationELFVLRMKEAYTHAQ
HHHHHHHHHHHHHHH
32.53-
854UbiquitinationVLRMKEAYTHAQISR
HHHHHHHHHHHHHHC
10.5123000965
857UbiquitinationMKEAYTHAQISRNNE
HHHHHHHHHHHCCCC
10.7023000965
866UbiquitinationISRNNELKDTLILTT
HHCCCCCCCEEEEEC
42.3521906983
866 (in isoform 1)Ubiquitination-42.3521890473
866 (in isoform 3)Ubiquitination-42.3521906983
868PhosphorylationRNNELKDTLILTTGD
CCCCCCCEEEEECCH
17.7024719451
873PhosphorylationKDTLILTTGDIGRAA
CCEEEEECCHHHHHC
29.4324719451
904PhosphorylationLSKSASVSGAAYTEI
HHCCCCCCCCHHHHH
21.8825690035
908PhosphorylationASVSGAAYTEIRALV
CCCCCCHHHHHHHHH
12.3625690035
918UbiquitinationIRALVAAKSVKLQSF
HHHHHHHHCHHHHHH
46.1523000965
919PhosphorylationRALVAAKSVKLQSFF
HHHHHHHCHHHHHHH
21.5417924679
921UbiquitinationLVAAKSVKLQSFFSQ
HHHHHCHHHHHHHHH
48.1523000965
941UbiquitinationCQFLVESLHSSQMTA
HHHHHHHHCCCCCCC
2.6221963094
941 (in isoform 2)Ubiquitination-2.6221890473
952PhosphorylationQMTALPNTPCQNADV
CCCCCCCCCCCCCCH
24.4128348404
993UbiquitinationDLNRFLTRTLQVLLP
CHHHHHHHHHHHHCH
35.2722053931
1005UbiquitinationLLPDLAAKASPAASA
HCHHHHHHCCHHHHH
43.7321906983
1005 (in isoform 1)Ubiquitination-43.7321890473
1005 (in isoform 3)Ubiquitination-43.7321906983
1007PhosphorylationPDLAAKASPAASALI
HHHHHHCCHHHHHHH
17.8626270265
1011PhosphorylationAKASPAASALIRTLG
HHCCHHHHHHHHHHH
26.2226270265
1016PhosphorylationAASALIRTLGKQLNV
HHHHHHHHHHHHCCC
32.6326270265
1019UbiquitinationALIRTLGKQLNVNRR
HHHHHHHHHCCCCHH
55.51-
1057UbiquitinationERALHYLKNETEIEL
HHHHHHHHCCHHHHH
45.6422053931
1057 (in isoform 1)Ubiquitination-45.6421890473
1122PhosphorylationSPELMADYLQPKLLG
CHHHHHHHHHHHHHH
9.56-
1140PhosphorylationFFNMQLLSSSVGIED
HHCHHHHHCCCCCCC
29.2024719451
1154PhosphorylationDKKMALNSLMSLMKL
CHHHHHHHHHHHHHH
26.7120068231
1157PhosphorylationMALNSLMSLMKLMGP
HHHHHHHHHHHHHCC
30.5229759185
1165UbiquitinationLMKLMGPKHVSSVRV
HHHHHCCCCHHHHHH
51.4129967540
1168PhosphorylationLMGPKHVSSVRVKMM
HHCCCCHHHHHHHHH
23.8820068231
1169PhosphorylationMGPKHVSSVRVKMMT
HCCCCHHHHHHHHHH
16.9220068231
1173AcetylationHVSSVRVKMMTTLRT
CHHHHHHHHHHHHCC
16.647666237
1173UbiquitinationHVSSVRVKMMTTLRT
CHHHHHHHHHHHHCC
16.64-
1185UbiquitinationLRTGLRFKDDFPELC
HCCCCCCCCCHHHHH
50.37-
1198UbiquitinationLCCRAWDCFVRCLDH
HHHHHHHHHHHHHCH
2.0721963094
1199UbiquitinationCCRAWDCFVRCLDHA
HHHHHHHHHHHHCHH
3.4422817900
1201UbiquitinationRAWDCFVRCLDHACL
HHHHHHHHHHCHHHH
8.6022817900
1244UbiquitinationLIIENRDAVQDFLHE
HHHCCHHHHHHHHHH
9.5321963094
1249UbiquitinationRDAVQDFLHEIYFLP
HHHHHHHHHHHHCCC
4.8222817900
1262UbiquitinationLPDHPELKKIKAVLQ
CCCCHHHHHHHHHHH
51.2821963094
1263UbiquitinationPDHPELKKIKAVLQE
CCCHHHHHHHHHHHH
63.1622817900
1265UbiquitinationHPELKKIKAVLQEYR
CHHHHHHHHHHHHHH
41.1222817900
1275PhosphorylationLQEYRKETSESTDLQ
HHHHHHHCCCCCCHH
40.61-
1308UbiquitinationIHALTSLKETLYKNQ
HHHHHHHHHHHHHCH
48.7121963094
1313UbiquitinationSLKETLYKNQEKLIK
HHHHHHHHCHHHHHH
56.0922817900
1333PhosphorylationETVEPIISQLVTVLL
CCHHHHHHHHHHHHH
20.41-
1399UbiquitinationFAYGLLMELTRAYLA
HHHHHHHHHHHHHHH
47.1322817900
1401UbiquitinationYGLLMELTRAYLAYA
HHHHHHHHHHHHHHH
10.4322817900
1403UbiquitinationLLMELTRAYLAYADN
HHHHHHHHHHHHHCC
9.8421963094
1405UbiquitinationMELTRAYLAYADNSR
HHHHHHHHHHHCCCC
2.6121963094
1463UbiquitinationPHLNTRYKSSQKSTD
HHHCCCCCCCCCCCC
40.1022817900
1465UbiquitinationLNTRYKSSQKSTDWS
HCCCCCCCCCCCCCC
37.1622817900
1467UbiquitinationTRYKSSQKSTDWSGV
CCCCCCCCCCCCCCC
58.2221963094
1469UbiquitinationYKSSQKSTDWSGVKK
CCCCCCCCCCCCCCC
48.8221963094
1475UbiquitinationSTDWSGVKKPIYLSK
CCCCCCCCCCEEHHH
57.2529967540
1476UbiquitinationTDWSGVKKPIYLSKL
CCCCCCCCCEEHHHC
33.9529967540
1479PhosphorylationSGVKKPIYLSKLGSN
CCCCCCEEHHHCCCC
17.2829759185
1544UbiquitinationLLGCNQEDQQEVYAE
HHCCCHHHHHHHHHH
45.7822817900
1546UbiquitinationGCNQEDQQEVYAEIM
CCCHHHHHHHHHHHH
55.2122817900
1549UbiquitinationQEDQQEVYAEIMAVL
HHHHHHHHHHHHHHH
9.5822817900
1549 (in isoform 2)Ubiquitination-9.5821890473
1551UbiquitinationDQQEVYAEIMAVLKH
HHHHHHHHHHHHHHC
18.6622817900
1566PhosphorylationDDQHTINTQDIASDL
CCCCCCCHHHHHHHH
24.6221908846
1578PhosphorylationSDLCQLSTQTVFSML
HHHHHHHHHHHHHHH
36.5321908846
1589PhosphorylationFSMLDHLTQWARHKF
HHHHHHHHHHHHHHH
20.7421908846
1600UbiquitinationRHKFQALKAEKCPHS
HHHHHHHHHHCCCCC
58.4733845483
1608UbiquitinationAEKCPHSKSNRNKVD
HHCCCCCCCCCCCCC
49.0322817900
1610UbiquitinationKCPHSKSNRNKVDSM
CCCCCCCCCCCCCCC
56.1122817900
1613UbiquitinationHSKSNRNKVDSMVST
CCCCCCCCCCCCCEE
44.1522817900
1613 (in isoform 1)Ubiquitination-44.1521890473
1613 (in isoform 3)Ubiquitination-44.1521906983
1615UbiquitinationKSNRNKVDSMVSTVD
CCCCCCCCCCCEECC
32.4022817900
1616PhosphorylationSNRNKVDSMVSTVDY
CCCCCCCCCCEECCH
24.8728555341
1639UbiquitinationFLDLIPQDTLAVASF
HHHCCCCCCEEHHHH
38.0321963094
1639 (in isoform 2)Ubiquitination-38.0321890473
1641UbiquitinationDLIPQDTLAVASFRS
HCCCCCCEEHHHHHC
4.9321963094
1645PhosphorylationQDTLAVASFRSKAYT
CCCEEHHHHHCHHHH
18.0024719451
1648PhosphorylationLAVASFRSKAYTRAV
EEHHHHHCHHHHHHH
21.4524719451
1651PhosphorylationASFRSKAYTRAVMHF
HHHHCHHHHHHHHHH
10.6524719451
1652PhosphorylationSFRSKAYTRAVMHFE
HHHCHHHHHHHHHHH
19.6028348404
1666UbiquitinationESFITEKKQNIQEHL
HHHHHHHHHHHHHHH
42.2029967540
1680PhosphorylationLGFLQKLYAAMHEPD
HHHHHHHHHHHCCCC
10.1924043423
1693PhosphorylationPDGVAGVSAIRKAEP
CCCCCCHHHHHHCCC
19.6324043423
1697UbiquitinationAGVSAIRKAEPSLKE
CCHHHHHHCCCCHHH
51.49-
1703UbiquitinationRKAEPSLKEQILEHE
HHCCCCHHHHHHHHH
52.4921906983
1703 (in isoform 1)Ubiquitination-52.4921890473
1703 (in isoform 3)Ubiquitination-52.4921906983
1705UbiquitinationAEPSLKEQILEHESL
CCCCHHHHHHHHHHH
43.9321963094
1732UbiquitinationAIQLEPDQIIHYHGV
CCCCCHHHHHEHHHH
47.4521963094
1734UbiquitinationQLEPDQIIHYHGVVK
CCCHHHHHEHHHHHH
1.8821963094
1760UbiquitinationITQVNGVHANRSEWT
HHHHCCCCCCCHHHC
20.7721963094
1760 (in isoform 2)Ubiquitination-20.7721890473
1762UbiquitinationQVNGVHANRSEWTDE
HHCCCCCCCHHHCHH
32.8821963094
1796UbiquitinationNYLAADGKSTTWSVR
HHHHCCCCCCCHHHH
45.2221963094
1798UbiquitinationLAADGKSTTWSVRLG
HHCCCCCCCHHHHHH
35.4521963094
1812UbiquitinationGQLLLSAKKRDITAF
HHHHHHHHHCCCHHH
44.99-
1824UbiquitinationTAFYDSLKLVRAEQI
HHHHHHHHHHCHHHH
49.2221906983
1824 (in isoform 1)Ubiquitination-49.2221890473
1824 (in isoform 3)Ubiquitination-49.2221906983
1826UbiquitinationFYDSLKLVRAEQIVP
HHHHHHHHCHHHHEE
5.3521963094
1871PhosphorylationIKPLFQHSPGDSSQE
CHHHHCCCCCCCCHH
21.5720363803
1875PhosphorylationFQHSPGDSSQEDSLN
HCCCCCCCCHHHHHH
39.5818691976
1876PhosphorylationQHSPGDSSQEDSLNW
CCCCCCCCHHHHHHH
42.1820363803
1880PhosphorylationGDSSQEDSLNWVARL
CCCCHHHHHHHHHHH
23.8927732954
1890PhosphorylationWVARLEMTQNSYRAK
HHHHHHHCCCCHHCC
18.4126552605
1893PhosphorylationRLEMTQNSYRAKEPI
HHHHCCCCHHCCHHH
13.2326552605
1894PhosphorylationLEMTQNSYRAKEPIL
HHHCCCCHHCCHHHH
23.3426552605
1897UbiquitinationTQNSYRAKEPILALR
CCCCHHCCHHHHHHH
55.83-
1912UbiquitinationRALLSLNKRPDYNEM
HHHHHCCCCCCHHHH
71.28-
1933UbiquitinationQSARVARKAGHHQTA
HHHHHHHHHCCHHHH
49.3229967540
1956PhosphorylationESRLAELYVERAKWL
HHHHHHHHHHHHHHH
7.5621955146
1989PhosphorylationLCFPENETPPEGKNM
EECCCCCCCCCCCCC
56.5825159151
1994UbiquitinationNETPPEGKNMLIHGR
CCCCCCCCCCEEHHH
37.21-
2013PhosphorylationVGRFMEETANFESNA
HHHHHHHHCCCCCCH
17.3730257219
2026AcetylationNAIMKKYKDVTACLP
CHHHHHHCCCCCCCC
55.3826051181
2026UbiquitinationNAIMKKYKDVTACLP
CHHHHHHCCCCCCCC
55.3829967540
2048UbiquitinationYLAKYYDKLMPMVTD
HHHHHHHHHHCHHCC
30.4829967540
2057UbiquitinationMPMVTDNKMEKQGDL
HCHHCCCCHHHCCHH
51.77-
2075O-linked_GlycosylationIVLHFGRSLQYGNQF
HHHHCCCCCHHCCHH
21.8730379171
2106UbiquitinationTKAYEWEKAGRSDRV
CCCHHHHHCCCCCCC
58.1629967540
2121UbiquitinationQMRNDLGKINKVITE
CHHHCHHHHHHHHHH
50.8629967540
2171PhosphorylationIAKVFLAYPQQAMWM
HHHHHHHCHHHHHHH
12.0626552605
2180PhosphorylationQQAMWMMTAVSKSSY
HHHHHHHHHHCCCCC
14.0624043423
2183PhosphorylationMWMMTAVSKSSYPMR
HHHHHHHCCCCCCCC
25.1024043423
2186PhosphorylationMTAVSKSSYPMRVNR
HHHHCCCCCCCCHHH
36.67-
2187PhosphorylationTAVSKSSYPMRVNRC
HHHCCCCCCCCHHHH
14.24-
2200UbiquitinationRCKEILNKAIHMKKS
HHHHHHHHHHHHHHH
45.3229967540
2210UbiquitinationHMKKSLEKFVGDATR
HHHHHHHHHHCHHHH
51.1229967540
2221UbiquitinationDATRLTDKLLELCNK
HHHHHHHHHHHHCCC
50.1429967540
2228AcetylationKLLELCNKPVDGSSS
HHHHHCCCCCCCCCC
45.4826051181
2228UbiquitinationKLLELCNKPVDGSSS
HHHHHCCCCCCCCCC
45.48-
2313PhosphorylationLQKPKKISLKGSDGK
CCCCCCEEEECCCCE
32.67-
2343PhosphorylationCRLMEFNSLINKCLR
HHHHHHHHHHHHHHH
35.6324719451
2347UbiquitinationEFNSLINKCLRKDAE
HHHHHHHHHHHHCHH
27.8729967540
2397UbiquitinationLTKLYKEKGVYMTGK
HHHHHHHHCCCCCHH
49.91-
2404AcetylationKGVYMTGKELRQCML
HCCCCCHHHHHHCCC
44.3926051181
2404UbiquitinationKGVYMTGKELRQCML
HCCCCCHHHHHHCCC
44.3929967540
2414O-linked_GlycosylationRQCMLPKSAALSEKL
HHCCCCCCHHHHHHH
19.4830379171
2420UbiquitinationKSAALSEKLKVFREF
CCHHHHHHHHHHHHH
50.6729967540
2506UbiquitinationFNKGETFEVPEIVPF
ECCCCCCCCCCEEEE
65.6622817900
2508UbiquitinationKGETFEVPEIVPFRL
CCCCCCCCCEEEEEC
20.5622817900
2510UbiquitinationETFEVPEIVPFRLTH
CCCCCCCEEEEECCC
3.7921963094
2512UbiquitinationFEVPEIVPFRLTHNM
CCCCCEEEEECCCCC
17.8221963094
2516PhosphorylationEIVPFRLTHNMVNGM
CEEEEECCCCCCCCC
13.6224043423
2523UbiquitinationTHNMVNGMGPMGTEG
CCCCCCCCCCCCHHH
4.6121963094
2523 (in isoform 2)Ubiquitination-4.6121890473
2525UbiquitinationNMVNGMGPMGTEGLF
CCCCCCCCCCHHHHH
14.7821963094
2527UbiquitinationVNGMGPMGTEGLFRR
CCCCCCCCHHHHHHH
24.6122817900
2528PhosphorylationNGMGPMGTEGLFRRA
CCCCCCCHHHHHHHH
22.1924043423
2540UbiquitinationRRACEVTMRLMRDQR
HHHHHHHHHHHHHCC
3.6021890473
2540 (in isoform 2)Ubiquitination-3.6021890473
2542UbiquitinationACEVTMRLMRDQREP
HHHHHHHHHHHCCHH
1.9921890473
2567UbiquitinationDPLVEWSKPVKGHSK
CCCCCCCCCCCCCCC
55.7029967540
2570UbiquitinationVEWSKPVKGHSKAPL
CCCCCCCCCCCCCCC
60.4722817900
2572UbiquitinationWSKPVKGHSKAPLNE
CCCCCCCCCCCCCCC
22.0222817900
2574UbiquitinationKPVKGHSKAPLNETG
CCCCCCCCCCCCCCC
48.6321963094
2576UbiquitinationVKGHSKAPLNETGEV
CCCCCCCCCCCCCCC
39.1821963094
2587UbiquitinationTGEVVNEKAKTHVLD
CCCCCCHHHHHHCCC
50.4021906983
2587 (in isoform 1)Ubiquitination-50.4021890473
2589UbiquitinationEVVNEKAKTHVLDIE
CCCCHHHHHHCCCHH
50.6721963094
2591UbiquitinationVNEKAKTHVLDIEQR
CCHHHHHHCCCHHHH
19.8922817900
2604UbiquitinationQRLQGVIKTRNRVTG
HHHHHHHHCCCCCCC
38.7422817900
2604 (in isoform 1)Ubiquitination-38.7421890473
2606UbiquitinationLQGVIKTRNRVTGLP
HHHHHHCCCCCCCCC
24.7721890473

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
291YPhosphorylationKinaseABL1P00519
GPS
310YPhosphorylationKinaseABL1P00519
GPS
428SPhosphorylationKinaseCDK1P06493
PSP
435SPhosphorylationKinasePRKACAP17612
GPS
1989TPhosphorylationKinaseATMQ13315
GPS
1989TPhosphorylationKinaseATRQ13535
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ATR_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ATR_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
BRCA1_HUMANBRCA1physical
11114888
P53_HUMANTP53physical
15159397
ABL1_HUMANABL1physical
10608806
AP1B1_HUMANAP1B1physical
10608806
ARHG1_HUMANARHGEF1physical
10608806
ATM_HUMANATMphysical
10608806
ATR_HUMANATRphysical
10608806
BRCA1_HUMANBRCA1physical
10608806
BRCA2_HUMANBRCA2physical
10608806
CHK1_HUMANCHEK1physical
10608806
E4F1_HUMANE4F1physical
10608806
DNLI4_HUMANLIG4physical
10608806
MRE11_HUMANMRE11Aphysical
10608806
NBN_HUMANNBNphysical
10608806
PA2G4_HUMANPA2G4physical
10608806
PK3CA_HUMANPIK3CAphysical
10608806
DPOD1_HUMANPOLD1physical
10608806
RAD17_HUMANRAD17physical
10608806
RFA1_HUMANRPA1physical
10608806
P53_HUMANTP53physical
10608806
WRN_HUMANWRNphysical
10608806
MCM2_HUMANMCM2physical
15210935
MSH2_HUMANMSH2physical
14657349
CLSPN_HUMANCLSPNphysical
12766152
CHD4_HUMANCHD4physical
10545197
HDAC2_HUMANHDAC2physical
10545197
HDAC1_HUMANHDAC1physical
10545197
MTA1_HUMANMTA1physical
10545197
MTA2_HUMANMTA2physical
10545197
ATRIP_HUMANATRIPphysical
14657349
ATRIP_HUMANATRIPphysical
11721054
RAD17_HUMANRAD17physical
11418864
H2AX_HUMANH2AFXphysical
19805520
XPC_HUMANXPCphysical
19805520
MSH6_HUMANMSH6physical
20029092
FANCA_HUMANFANCAphysical
19109555
ATRIP_HUMANATRIPphysical
19097996
TOPB1_HUMANTOPBP1physical
19097996
ATM_HUMANATMphysical
17124492
RFA2_HUMANRPA2physical
17035231
CHK2_HUMANCHEK2physical
17035231
RENT1_HUMANUPF1physical
16488880
CE164_HUMANCEP164physical
18283122
ATRIP_HUMANATRIPphysical
18283122
ATRIP_HUMANATRIPphysical
15451423
RAD1_HUMANRAD1physical
18162465
HUS1_HUMANHUS1physical
18162465
RAD9A_HUMANRAD9Aphysical
18162465
RFA1_HUMANRPA1physical
18162465
ATRIP_HUMANATRIPphysical
18162465
ATRIP_HUMANATRIPphysical
21285353
MSH2_HUMANMSH2physical
21285353
DPOLN_HUMANPOLNphysical
21242293
BLM_HUMANBLMphysical
14729972
EP300_HUMANEP300physical
17272271
MTA1_HUMANMTA1physical
20427275
ATRIP_HUMANATRIPphysical
17384638
WRN_HUMANWRNphysical
17118963
FACD2_HUMANFANCD2physical
16943440
E2F1_HUMANE2F1physical
11459832
P53_HUMANTP53physical
11459832
P53_HUMANTP53physical
20798688
ABL1_HUMANABL1physical
20798688
CHK2_HUMANCHEK2physical
10973490
HS90A_HUMANHSP90AA1physical
21566061
HSP74_HUMANHSPA4physical
21566061
ATRIP_HUMANATRIPphysical
15758953
WRN_HUMANWRNphysical
22159421
P53_HUMANTP53physical
10435622
CDC5L_HUMANCDC5Lphysical
19633697
BRCA1_HUMANBRCA1physical
11016625
CHK1_HUMANCHEK1physical
19330022
DCAF1_HUMANVPRBPphysical
22184063
H2AX_HUMANH2AFXphysical
22184063
DCR1C_HUMANDCLRE1Cphysical
15456891
BRCA1_HUMANBRCA1physical
11278964
DTL_HUMANDTLphysical
23029527
SOCS1_HUMANSOCS1physical
20005840
CHK1_HUMANCHEK1physical
11390642
XPA_HUMANXPAphysical
16540648
CCNB2_HUMANCCNB2physical
22939629
P53_HUMANTP53physical
15775976
CHK1_HUMANCHEK1physical
15775976
ATRIP_HUMANATRIPphysical
14724280
RAD17_HUMANRAD17physical
14724280
CDN2C_HUMANCDKN2Cphysical
15680327
CREB1_HUMANCREB1physical
16293623
P53_HUMANTP53physical
16293623
RAD17_HUMANRAD17physical
20424596
BID_MOUSEBidphysical
16122425
ATRIP_HUMANATRIPphysical
17686975
CHK1_HUMANCHEK1physical
17686975
BID_MOUSEBidphysical
16122426
CINP_HUMANCINPphysical
19889979
ATRIP_HUMANATRIPphysical
19889979
CHK1_HUMANCHEK1physical
21566061
XPC_HUMANXPCphysical
23422745
CLH1_HUMANCLTCphysical
25852190
YBOX3_HUMANYBX3physical
25852190
F133B_HUMANFAM133Bphysical
25852190
PABP2_HUMANPABPN1physical
25852190
NOSIP_HUMANNOSIPphysical
26344197
P2R3A_HUMANPPP2R3Aphysical
10608806
RASF1_HUMANRASSF1physical
10608806
AP3B1_HUMANAP3B1physical
10608806
TERT_HUMANTERTgenetic
23284306
ETV1_HUMANETV1physical
23284306
ETV1_HUMANETV1genetic
23284306
UBP20_HUMANUSP20physical
25326330
FACD2_HUMANFANCD2physical
14988723
ATR_HUMANATRphysical
22258451
FACD2_HUMANFANCD2physical
22258451
FANCI_HUMANFANCIphysical
22258451
TELO2_HUMANTELO2physical
17384638
TELO2_HUMANTELO2physical
19097996

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
210600Seckel syndrome 1 (SCKL1)
614564Cutaneous telangiectasia and cancer syndrome, familial (FCTCS)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ATR_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428; SER-435 ANDTHR-1989, AND MASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-919, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1989, AND MASSSPECTROMETRY.

TOP